Conditions: Venous Thrombosis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 2711
Healthy volunteers: no

Brief summary:
The purpose is to evaluate the effects of an investigational blood thinner, apixaban, in preventing venous thromboembolic (VTE) recurrence or death in patients who have completed their intended treatment for deep vein thrombosis (DVT) or pulmonary embolism (PE)

Detailed description:

Arms:
arm 1: 2.5 mg arm 2: 5.0 mg arm 3: 0 mg

Interventions: intervention 1: Apixaban intervention 2: Placebo
Intervention descriptions: intervention 1: Tablets, Oral, twice daily, 12 months intervention 2: Tablets, Oral, twice daily, 12 months

Protocol document: